APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sunitinib Malate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sunitinib Malate Industry Growth and Trends Forecast to 2032

26 December 202594 pages

Choose your research edition.

Industry ResearchSunitinib Malate Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sunitinib Malate Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Sunitinib Malate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sunitinib Malate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sunitinib Malate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sunitinib Malate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sunitinib Malate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sunitinib Malate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sunitinib Malate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sunitinib Malate include CSPC, Qilu Pharmaceutical, Nanjing First Pharmaceutical Co., Ltd., Hansoh Pharma, Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Target Molecule Corp. and J&K Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sunitinib Malate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sunitinib Malate market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sunitinib Malate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sunitinib Malate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sunitinib Malate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sunitinib Malate Market by Company

CSPC

Qilu Pharmaceutical

Nanjing First Pharmaceutical Co., Ltd.

Hansoh Pharma

Pfizer Sutent

Topcare pharmaceutical Co., Ltd

Target Molecule Corp.

J&K Scientific

Sunitinib Malate Segment by Type

12.5mg

37.5mg

50mg

Sunitinib Malate Segment by Application

Advanced Kidney Cancer

GIST (Gastrointestinal Stromal Tumor)

Pancreatic Neuroendocrine Tumors

Sunitinib Malate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sunitinib Malate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sunitinib Malate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sunitinib Malate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sunitinib Malate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sunitinib Malate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 12.5mg Table 2. Major Company of 37.5mg Table 3. Major Company of 50mg Table 4. Global Sunitinib Malate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 6. Global Sunitinib Malate Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sunitinib Malate Sales Market Share in Value by Type (2021-2026) Table 9. Global Sunitinib Malate Price by Type (2021-2026) & (US$/Unit) Table 10. Global Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 11. Global Sunitinib Malate Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sunitinib Malate Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sunitinib Malate Sales Market Share in Value by Type (2027-2032) Table 14. Global Sunitinib Malate Price by Type (2027-2032) & (US$/Unit) Table 15. North America Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 16. North America Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 18. Europe Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 22. Latin America Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Sunitinib Malate Sales by Type (2021-2026) & (US$ Million) Table 25. Sunitinib Malate Industry Trends Table 26. Sunitinib Malate Industry Drivers Table 27. Sunitinib Malate Industry Opportunities and Challenges Table 28. Sunitinib Malate Industry Restraints Table 29. Global Sunitinib Malate Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sunitinib Malate Revenue Market Share by Company (2021-2026) Table 31. Global Sunitinib Malate Sales by Company (2021-2026) & (Units) Table 32. Global Sunitinib Malate Sales Share by Company (2021-2026) Table 33. Global Sunitinib Malate Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Sunitinib Malate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sunitinib Malate Major Company Production Sites and Headquarters Table 36. Global Sunitinib Malate Company, Product Type & Application Table 37. Global Sunitinib Malate Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sunitinib Malate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sunitinib Malate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sunitinib Malate Sales by Region (2021-2026) & (Units) Table 42. Global Sunitinib Malate Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sunitinib Malate Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sunitinib Malate Sales Market Share in Value by Region (2021-2026) Table 45. Global Sunitinib Malate Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Sunitinib Malate Sales by Region (2027-2032) & (Units) Table 47. Global Sunitinib Malate Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sunitinib Malate Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sunitinib Malate Sales Market Share in Value by Region (2027-2032) Table 50. Global Sunitinib Malate Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Sunitinib Malate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 53. Global Sunitinib Malate Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sunitinib Malate Sales Market Share in Value by Application (2021-2026) Table 56. Global Sunitinib Malate Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 58. Global Sunitinib Malate Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sunitinib Malate Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sunitinib Malate Sales Market Share in Value by Application (2027-2032) Table 61. Global Sunitinib Malate Price by Application (2027-2032) & (US$/Unit) Table 62. North America Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 63. North America Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 65. Europe Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 69. Latin America Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Sunitinib Malate Sales by Application (2021-2026) & (US$ Million) Table 72. CSPC Company Information Table 73. CSPC Business Overview Table 74. CSPC Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CSPC Sunitinib Malate Product Portfolio Table 76. CSPC Recent Development Table 77. Qilu Pharmaceutical Company Information Table 78. Qilu Pharmaceutical Business Overview Table 79. Qilu Pharmaceutical Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Qilu Pharmaceutical Sunitinib Malate Product Portfolio Table 81. Qilu Pharmaceutical Recent Development Table 82. Nanjing First Pharmaceutical Co., Ltd. Company Information Table 83. Nanjing First Pharmaceutical Co., Ltd. Business Overview Table 84. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio Table 86. Nanjing First Pharmaceutical Co., Ltd. Recent Development Table 87. Hansoh Pharma Company Information Table 88. Hansoh Pharma Business Overview Table 89. Hansoh Pharma Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hansoh Pharma Sunitinib Malate Product Portfolio Table 91. Hansoh Pharma Recent Development Table 92. Pfizer Sutent Company Information Table 93. Pfizer Sutent Business Overview Table 94. Pfizer Sutent Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Sutent Sunitinib Malate Product Portfolio Table 96. Pfizer Sutent Recent Development Table 97. Topcare pharmaceutical Co., Ltd Company Information Table 98. Topcare pharmaceutical Co., Ltd Business Overview Table 99. Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio Table 101. Topcare pharmaceutical Co., Ltd Recent Development Table 102. Target Molecule Corp. Company Information Table 103. Target Molecule Corp. Business Overview Table 104. Target Molecule Corp. Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Target Molecule Corp. Sunitinib Malate Product Portfolio Table 106. Target Molecule Corp. Recent Development Table 107. J&K Scientific Company Information Table 108. J&K Scientific Business Overview Table 109. J&K Scientific Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. J&K Scientific Sunitinib Malate Product Portfolio Table 111. J&K Scientific Recent Development Table 112. North America Sunitinib Malate Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 113. North America Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 114. North America Sunitinib Malate Sales Market Share by Country (2021-2026) Table 115. North America Sunitinib Malate Sales Forecast by Country (2027-2032) & (Units) Table 116. North America Sunitinib Malate Sales Market Share Forecast by Country (2027-2032) Table 117. North America Sunitinib Malate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Sunitinib Malate Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Sunitinib Malate Market Share by Country (2021-2026) Table 120. North America Sunitinib Malate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Sunitinib Malate Market Share Forecast by Country (2027-2032) Table 122. Europe Sunitinib Malate Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 123. Europe Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 124. Europe Sunitinib Malate Sales Market Share by Country (2021-2026) Table 125. Europe Sunitinib Malate Sales Forecast by Country (2027-2032) & (Units) Table 126. Europe Sunitinib Malate Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Sunitinib Malate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Sunitinib Malate Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Sunitinib Malate Market Share by Country (2021-2026) Table 130. Europe Sunitinib Malate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Sunitinib Malate Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Sunitinib Malate Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 134. Asia-Pacific Sunitinib Malate Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Sunitinib Malate Sales Forecast by Country (2027-2032) & (Units) Table 136. Asia-Pacific Sunitinib Malate Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Sunitinib Malate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Sunitinib Malate Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Sunitinib Malate Market Share by Country (2021-2026) Table 140. Asia-Pacific Sunitinib Malate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Sunitinib Malate Market Share Forecast by Country (2027-2032) Table 142. Latin America Sunitinib Malate Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 143. Latin America Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 144. Latin America Sunitinib Malate Sales Market Share by Country (2021-2026) Table 145. Latin America Sunitinib Malate Sales Forecast by Country (2027-2032) & (Units) Table 146. Latin America Sunitinib Malate Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Sunitinib Malate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Sunitinib Malate Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Sunitinib Malate Market Share by Country (2021-2026) Table 150. Latin America Sunitinib Malate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Sunitinib Malate Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Sunitinib Malate Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 154. Middle East and Africa Sunitinib Malate Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Sunitinib Malate Sales Forecast by Country (2027-2032) & (Units) Table 156. Middle East and Africa Sunitinib Malate Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Sunitinib Malate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Sunitinib Malate Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Sunitinib Malate Market Share by Country (2021-2026) Table 160. Middle East and Africa Sunitinib Malate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Sunitinib Malate Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Sunitinib Malate Distributors List Table 165. Sunitinib Malate Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Sunitinib Malate Image Figure 2. Global Sunitinib Malate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sunitinib Malate Market Size (2021-2032) & (US$ Million) Figure 4. Global Sunitinib Malate Sales (2021-2032) & (Units) Figure 5. 12.5mg Image Figure 6. Global 12.5mg Sales YoY Growth (2021-2032) & (Units) Figure 7. 37.5mg Image Figure 8. Global 37.5mg Sales YoY Growth (2021-2032) & (Units) Figure 9. 50mg Image Figure 10. Global 50mg Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Sunitinib Malate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sunitinib Malate Market Share by Type 2025 VS 2032 Figure 13. North America Sunitinib Malate Sales Market Share in Volume by Type in 2025 Figure 14. North America Sunitinib Malate Sales Market Share in Value by Type in 2025 Figure 15. Europe Sunitinib Malate Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sunitinib Malate Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sunitinib Malate Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sunitinib Malate Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sunitinib Malate Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sunitinib Malate Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sunitinib Malate Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sunitinib Malate Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sunitinib Malate Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Advanced Kidney Cancer Image Figure 26. Global Advanced Kidney Cancer Sales YoY Growth (2021-2032) & (Units) Figure 27. GIST (Gastrointestinal Stromal Tumor) Image Figure 28. Global GIST (Gastrointestinal Stromal Tumor) Sales YoY Growth (2021-2032) & (Units) Figure 29. Pancreatic Neuroendocrine Tumors Image Figure 30. Global Pancreatic Neuroendocrine Tumors Sales YoY Growth (2021-2032) & (Units) Figure 31. Global Sunitinib Malate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sunitinib Malate Market Share by Application 2025 VS 2032 Figure 33. North America Sunitinib Malate Sales Market Share in Volume by Application in 2025 Figure 34. North America Sunitinib Malate Sales Market Share in Value by Application in 2025 Figure 35. Europe Sunitinib Malate Sales Market Share in Volume by Application in 2025 Figure 36. Europe Sunitinib Malate Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Sunitinib Malate Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Sunitinib Malate Sales Market Share in Value by Application in 2025 Figure 39. Latin America Sunitinib Malate Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Sunitinib Malate Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Sunitinib Malate Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Sunitinib Malate Sales Market Share in Value by Application in 2025 Figure 43. North America Sunitinib Malate Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 44. North America Sunitinib Malate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Sunitinib Malate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Sunitinib Malate Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sunitinib Malate Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. Europe Sunitinib Malate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sunitinib Malate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Sunitinib Malate Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sunitinib Malate Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Asia-Pacific Sunitinib Malate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sunitinib Malate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Sunitinib Malate Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sunitinib Malate Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Latin America Sunitinib Malate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sunitinib Malate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Sunitinib Malate Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sunitinib Malate Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Middle East and Africa Sunitinib Malate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sunitinib Malate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Sunitinib Malate Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Sunitinib Malate Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Sunitinib Malate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 12.5mg
  • 37.5mg
  • 50mg
Applications
  • Advanced Kidney Cancer
  • GIST (Gastrointestinal Stromal Tumor)
  • Pancreatic Neuroendocrine Tumors
Companies covered
  • CSPC
  • Qilu Pharmaceutical
  • Nanjing First Pharmaceutical Co., Ltd.
  • Hansoh Pharma
  • Pfizer Sutent
  • Topcare pharmaceutical Co., Ltd
  • Target Molecule Corp.
  • J&K Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sunitinib Malate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sunitinib Malate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sunitinib Malate Market by Type
  6. 1.3.1 12.5mg
  7. 1.3.2 37.5mg
  8. 1.3.3 50mg
  9. 1.4 Global Sunitinib Malate Market Size by Type
  10. 1.4.1 Global Sunitinib Malate Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sunitinib Malate Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sunitinib Malate Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sunitinib Malate Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sunitinib Malate Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sunitinib Malate Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sunitinib Malate Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sunitinib Malate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sunitinib Malate Industry Trends
  2. 2.2 Sunitinib Malate Industry Drivers
  3. 2.3 Sunitinib Malate Industry Opportunities and Challenges
  4. 2.4 Sunitinib Malate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sunitinib Malate Revenue (2021-2026)
  2. 3.2 Global Top Players by Sunitinib Malate Sales (2021-2026)
  3. 3.3 Global Top Players by Sunitinib Malate Price (2021-2026)
  4. 3.4 Global Sunitinib Malate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sunitinib Malate Major Company Production Sites & Headquarters
  6. 3.6 Global Sunitinib Malate Company, Product Type & Application
  7. 3.7 Global Sunitinib Malate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sunitinib Malate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sunitinib Malate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sunitinib Malate Tier 1, Tier 2, and Tier 3
4 Sunitinib Malate Regional Status and Outlook
  1. 4.1 Global Sunitinib Malate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sunitinib Malate Historic Market Size by Region
  3. 4.2.1 Global Sunitinib Malate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sunitinib Malate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sunitinib Malate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sunitinib Malate Forecasted Market Size by Region
  7. 4.3.1 Global Sunitinib Malate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sunitinib Malate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sunitinib Malate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sunitinib Malate by Application
  1. 5.1 Sunitinib Malate Market by Application
  2. 5.1.1 Advanced Kidney Cancer
  3. 5.1.2 GIST (Gastrointestinal Stromal Tumor)
  4. 5.1.3 Pancreatic Neuroendocrine Tumors
  5. 5.2 Global Sunitinib Malate Market Size by Application
  6. 5.2.1 Global Sunitinib Malate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sunitinib Malate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sunitinib Malate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sunitinib Malate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sunitinib Malate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sunitinib Malate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sunitinib Malate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sunitinib Malate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSPC
  2. 6.1.1 CSPC Company Information
  3. 6.1.2 CSPC Business Overview
  4. 6.1.3 CSPC Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSPC Sunitinib Malate Product Portfolio
  6. 6.1.5 CSPC Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Sunitinib Malate Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Nanjing First Pharmaceutical Co., Ltd.
  14. 6.3.1 Nanjing First Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Nanjing First Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio
  18. 6.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Hansoh Pharma
  20. 6.4.1 Hansoh Pharma Company Information
  21. 6.4.2 Hansoh Pharma Business Overview
  22. 6.4.3 Hansoh Pharma Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hansoh Pharma Sunitinib Malate Product Portfolio
  24. 6.4.5 Hansoh Pharma Recent Developments
  25. 6.5 Pfizer Sutent
  26. 6.5.1 Pfizer Sutent Company Information
  27. 6.5.2 Pfizer Sutent Business Overview
  28. 6.5.3 Pfizer Sutent Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Sutent Sunitinib Malate Product Portfolio
  30. 6.5.5 Pfizer Sutent Recent Developments
  31. 6.6 Topcare pharmaceutical Co., Ltd
  32. 6.6.1 Topcare pharmaceutical Co., Ltd Company Information
  33. 6.6.2 Topcare pharmaceutical Co., Ltd Business Overview
  34. 6.6.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio
  36. 6.6.5 Topcare pharmaceutical Co., Ltd Recent Developments
  37. 6.7 Target Molecule Corp.
  38. 6.7.1 Target Molecule Corp. Company Information
  39. 6.7.2 Target Molecule Corp. Business Overview
  40. 6.7.3 Target Molecule Corp. Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Target Molecule Corp. Sunitinib Malate Product Portfolio
  42. 6.7.5 Target Molecule Corp. Recent Developments
  43. 6.8 J&K Scientific
  44. 6.8.1 J&K Scientific Company Information
  45. 6.8.2 J&K Scientific Business Overview
  46. 6.8.3 J&K Scientific Sunitinib Malate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 J&K Scientific Sunitinib Malate Product Portfolio
  48. 6.8.5 J&K Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Sunitinib Malate Sales by Country
  2. 7.1.1 North America Sunitinib Malate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sunitinib Malate Sales by Country (2021-2026)
  4. 7.1.3 North America Sunitinib Malate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sunitinib Malate Market Size by Country
  6. 7.2.1 North America Sunitinib Malate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sunitinib Malate Market Size by Country (2021-2026)
  8. 7.2.3 North America Sunitinib Malate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sunitinib Malate Sales by Country
  2. 8.1.1 Europe Sunitinib Malate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sunitinib Malate Sales by Country (2021-2026)
  4. 8.1.3 Europe Sunitinib Malate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sunitinib Malate Market Size by Country
  6. 8.2.1 Europe Sunitinib Malate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sunitinib Malate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sunitinib Malate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sunitinib Malate Sales by Country
  2. 9.1.1 Asia-Pacific Sunitinib Malate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sunitinib Malate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sunitinib Malate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sunitinib Malate Market Size by Country
  6. 9.2.1 Asia-Pacific Sunitinib Malate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sunitinib Malate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sunitinib Malate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sunitinib Malate Sales by Country
  2. 10.1.1 South America Sunitinib Malate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sunitinib Malate Sales by Country (2021-2026)
  4. 10.1.3 South America Sunitinib Malate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sunitinib Malate Market Size by Country
  6. 10.2.1 South America Sunitinib Malate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sunitinib Malate Market Size by Country (2021-2026)
  8. 10.2.3 South America Sunitinib Malate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sunitinib Malate Sales by Country
  2. 11.1.1 Middle East and Africa Sunitinib Malate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sunitinib Malate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sunitinib Malate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sunitinib Malate Market Size by Country
  6. 11.2.1 Middle East and Africa Sunitinib Malate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sunitinib Malate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sunitinib Malate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sunitinib Malate Value Chain Analysis
  2. 12.1.1 Sunitinib Malate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sunitinib Malate Production Mode & Process
  7. 12.2 Sunitinib Malate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sunitinib Malate Distributors
  10. 12.2.3 Sunitinib Malate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst